drugset / Trial / NCT06548906

A Study of GZR4 Injection at Different Injection Sites

NCT06548906

Phase 1 Recruiting 24 enrolled Gan and Lee Pharmaceuticals, USA
RandomizedCrossoverOpen-labelTreatment

Summary

This trial is conducted in China. This study is a randomized, single-center, open, three-period crossover trial in healthy subjects to compare the PK, PD, and safety of a single administration of GZR4 at different injection sites (abdomen, deltoid region of upper arm, and thigh).

Timeline

Start
2024-05-08
Primary completion
2024-08-31
Completion
2024-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject GZR4 Unknown Subcutaneous

Indications

No indication recorded.